BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37099088)

  • 1. The Impact of the COVID-19 Pandemic on Hepatocellular Carcinoma Time to Treatment Initiation: A National Cancer Database Study.
    Rasic G; Beaulieu-Jones BR; Chung SH; Romatoski KS; Kenzik K; Ng SC; Tseng JF; Sachs TE
    Ann Surg Oncol; 2023 Jul; 30(7):4249-4259. PubMed ID: 37099088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Underuse and Delay in Hepatocellular Carcinoma: Prevalence, Associated Factors, and Clinical Impact.
    Govalan R; Luu M; Lauzon M; Kosari K; Ahn JC; Rich NE; Nissen N; Roberts LR; Singal AG; Yang JD
    Hepatol Commun; 2022 Jan; 6(1):223-236. PubMed ID: 34558830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Single Turkey Center Study.
    Bilican G; Özgül S; Ekmen N; Moral K; Küçük H; Dumanlı S; Abiyev A; Karakan T; Kekilli M
    J Gastrointestin Liver Dis; 2023 Sep; 32(3):367-370. PubMed ID: 37774229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
    Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Time-to-Treatment Initiation and Survival in a Cohort of Patients With Common Cancers.
    Cone EB; Marchese M; Paciotti M; Nguyen DD; Nabi J; Cole AP; Molina G; Molina RL; Minami CA; Mucci LA; Kibel AS; Trinh QD
    JAMA Netw Open; 2020 Dec; 3(12):e2030072. PubMed ID: 33315115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of COVID-19 on the diagnosis and treatment of HCC: analysis of a nationwide registry for advanced liver diseases (REAL).
    Okushin K; Tateishi R; Hirakawa S; Tachimori H; Uchino K; Nakagomi R; Yamada T; Nakatsuka T; Minami T; Sato M; Fujishiro M; Hasegawa K; Eguchi Y; Kanto T; Yoshiji H; Izumi N; Kudo M; Koike K
    Sci Rep; 2024 Feb; 14(1):2826. PubMed ID: 38310156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicaid and Uninsured Hepatocellular Carcinoma Patients Have More Advanced Tumor Stage and Are Less Likely to Receive Treatment.
    Wang J; Ha J; Lopez A; Bhuket T; Liu B; Wong RJ
    J Clin Gastroenterol; 2018; 52(5):437-443. PubMed ID: 28723861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United States.
    Cushman TR; Jones B; Akhavan D; Rusthoven CG; Verma V; Salgia R; Sedrak M; Massarelli E; Welsh JW; Amini A
    Clin Lung Cancer; 2021 Jan; 22(1):e84-e97. PubMed ID: 33039348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with an increased time to treatment initiation have a poorer overall survival after definitive surgery for localized high-grade soft-tissue sarcoma in the extremity or trunk : report from the National Cancer Database.
    Ogura K; Fujiwara T; Healey JH
    Bone Joint J; 2021 Jun; 103-B(6):1142-1149. PubMed ID: 34058874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Medicaid expansion with 2-year survival and time to treatment initiation in gastrointestinal cancer patients: A National Cancer Database study.
    Mobley EM; Chen G; Xu J; Edgar L; Pather K; Daly MC; Awad ZT; Parker AS; Xie Z; Suk R; Mathews S; Hong YR
    J Surg Oncol; 2023 Dec; 128(8):1285-1301. PubMed ID: 37781956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and Therapeutic Delays in Patients With Hepatocellular Carcinoma.
    Rao A; Rich NE; Marrero JA; Yopp AC; Singal AG
    J Natl Compr Canc Netw; 2021 May; 19(9):1063-1071. PubMed ID: 34077908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatopancreatobiliary malignancies: time to treatment matters.
    Kerekes DM; Frey AE; Bakkila BF; Johnson CH; Becher RD; Billingsley KG; Khan SA
    J Gastrointest Oncol; 2023 Apr; 14(2):833-848. PubMed ID: 37201090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the COVID-19 Pandemic on Treatment Patterns for Patients With Metastatic Solid Cancer in the United States.
    Parikh RB; Takvorian SU; Vader D; Paul Wileyto E; Clark AS; Lee DJ; Goyal G; Rocque GB; Dotan E; Geynisman DM; Phull P; Spiess PE; Kim RY; Davidoff AJ; Gross CP; Neparidze N; Miksad RA; Calip GS; Hearn CM; Ferrell W; Shulman LN; Mamtani R; Hubbard RA;
    J Natl Cancer Inst; 2022 Apr; 114(4):571-578. PubMed ID: 34893865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.
    El-Serag HB; Siegel AB; Davila JA; Shaib YH; Cayton-Woody M; McBride R; McGlynn KA
    J Hepatol; 2006 Jan; 44(1):158-66. PubMed ID: 16290309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparate impact of the COVID-19 pandemic on delays in colorectal cancer treatment: A National Cancer Database study.
    Chung SH; Rasic G; Romatoski KS; Kenzik K; Tseng JF; Sachs TE
    Surgery; 2024 Apr; 175(4):1013-1020. PubMed ID: 38245445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Medicaid Expansion on Receipt of Definitive Treatment and Time to Treatment Initiation by Racial and Ethnic Minorities and at Minority-Serving Hospitals: A Patient-Level and Facility-Level Analysis of Breast, Colon, Lung, and Prostate Cancer.
    Nguyen DD; Paciotti M; Marchese M; Cole AP; Cone EB; Kibel AS; Ortega G; Lipsitz SR; Weissman JS; Trinh QD
    JCO Oncol Pract; 2021 May; 17(5):e654-e665. PubMed ID: 33974827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Medicaid Expansion Under the Affordable Care Act With Stage at Diagnosis and Time to Treatment Initiation for Patients With Head and Neck Squamous Cell Carcinoma.
    Sineshaw HM; Ellis MA; Yabroff KR; Han X; Jemal A; Day TA; Graboyes EM
    JAMA Otolaryngol Head Neck Surg; 2020 Mar; 146(3):247-255. PubMed ID: 31944232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing time to treatment initiation for head and neck cancer: an analysis of the National Cancer Database.
    Murphy CT; Galloway TJ; Handorf EA; Wang L; Mehra R; Flieder DB; Ridge JA
    Cancer; 2015 Apr; 121(8):1204-13. PubMed ID: 25490875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Race/Ethnicity and Insurance Status with Outcomes in Patients with Hepatocellular Carcinoma.
    Scaglione S; Adams W; Caines A; Devlin P; Mittal S; Singal AG; Parikh ND
    Dig Dis Sci; 2020 Jun; 65(6):1669-1678. PubMed ID: 31643036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult soft tissue sarcoma and time to treatment initiation: An analysis of the National Cancer Database.
    Curtis GL; Lawrenz JM; George J; Styron JF; Scott J; Shah C; Shepard DR; Rubin B; Nystrom LM; Mesko NW
    J Surg Oncol; 2018 Jun; 117(8):1776-1785. PubMed ID: 29949654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.